EKSO: RWLK competitor. $1.50 share secondary done. Major deals pending. EKSO has more potential than RWLK now. RWLK bringing eyes to sector & EKSO next big mover. EKSO has medical uses but even bigger global industrial and sports market. $10M offering closed last week. https://finance.yahoo.com/news/ekso-bionics-announces-closing-10-200100964.html LINK: https://eksobionics.com/